drugset / Trial / NCT04292444

Effects of Oxytocin on Cognitive and Reactive Fear

NCT04292444

Phase 1 Unknown 60 enrolled University Hospital, Bonn
RandomizedCrossoverDouble-blindBasic science

Summary

The study examines the (sub)regional specificity of anxiolytic oxytocin (OXT) effects on emotional face processing and reactive and cognitive fear. Preliminary data indicate that the Receptor for Advanced Glycation End Products (RAGE) may regulate oxytocin transport into the brain. Thus, the study aims to replicate previous observations of oxytocin effects on the processing of fearful faces in the centro-medial amygdala and to assess whether a RAGE polymorphism (-374 T/A: rs1800624; TT vs. TA/AA), that has been shown to alter transcriptional activity, modulates anxiolytic OXT effects.

Timeline

Start
2019-12-13
Primary completion
2021-05
Completion
2021-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Oxytocin Peptide 24 iu Intranasal

Indications

No indication recorded.